Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Sadegh Dastorani, Mahmoud Shariati, Reza Hasanzadeh Ghasemi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global challenges to public health care systems during the COVID-19 pandemic: a review of pandemic measures and problems
10.3390/jpm12081295 · 2022
COVID-19. A review
10.4081/monaldi.2020.1298 · 2020
Current progress, challenges and prospects in the development of COVID-19 vaccines
10.1007/s40265-024-02013-8 · 2024
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
10.1080/07391102.2020.1754293 · 2020
Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting Enzyme)-2 as their main receptor
10.1161/hypertensionaha.120.15256 · 2020
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
10.1038/s41392-020-00318-0 · 2020
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
10.1038/s41423-020-0400-4 · 2020
Biotechnological perspectives to combat the COVID-19 pandemic: precise diagnostics and inevitable vaccine paradigms
10.3390/cells11071182 · 2022
Structural understanding of SARS-CoV-2 virus entry to host cells
10.3389/fmolb.2023.1288686 · 2023
COVID-19, coagulopathy and venous thromboembolism: more questions than answers
10.1007/s11739-020-02432-x · 2020
Heparin, heparan sulphate and sepsis: potential new options for treatment
10.3390/ph16020271 · 2023
The benefits of heparin use in COVID-19: pleiotropic antiviral activity beyond anticoagulant and anti-inflammatory properties
10.1055/s-0042-1742740 · 2022
Structural characteristics of heparin binding to SARS-CoV-2 spike protein RBD of omicron sub-lineages BA.2.12.1, BA.4 and BA.5
10.3390/v14122696 · 2022
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms
10.1016/j.jbc.2021.101507 · 2022
Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin
10.1055/s-0040-1721319 · 2020
Adverse Effects of Heparin
2011
DNA origami
10.1038/s43586-021-00027-8 · 2021
Engineering and molecular dynamics simulation of DNA origami-heparin nanostructures for antiviral applications
10.1142/s2737416525500620 · 2026
Folding DNA to create nanoscale shapes and patterns
10.1038/nature04586 · 2006
Modelling and structural investigation of a new DNA origami based flexible bio-nano joint
10.1080/08927022.2020.1797019 · 2020
A study on the bending stiffness of a new DNA origami nano-joint
10.1007/s12033-021-00367-y · 2021
Self-assembly of DNA into nanoscale three-dimensional shapes
10.1038/nature08016 · 2009
Analysis of the binding affinity of SARS-CoV-2 spike RBD to novel DNA origami-heparin nanostructures: a steered molecular dynamics (SMD) study
10.1080/07391102.2025.2594661 · 2025
DNA origami traps for large viruses
10.1016/j.xcrp.2022.101237 · 2023
Broad-spectrum virus trapping with heparan sulfate-modified DNA origami shells
10.1021/acsnano.1c11328 · 2022
Self‐assembled multivalent (SAMul) polyanion binding—impact of hydrophobic modifications in the micellar core on DNA and heparin binding at the peripheral cationic ligands
10.1002/chem.201700177 · 2017
Electrostatic binding of polyanions using self-assembled multivalent (SAMul) ligand displays—structure–activity effects on DNA/heparin binding
10.1039/c5sc04801j · 2016
Perceptions and misconceptions in molecular recognition: key factors in self-assembling multivalent (SAMul) ligands/polyanions selectivity
10.3390/molecules25041003 · 2020
Rapid prototyping of 3D DNA-origami shapes with caDNAno
10.1093/nar/gkp436 · 2009
Design, optimization and analysis of large DNA and RNA nanostructures through interactive visualization, editing and molecular simulation
10.1093/nar/gkaa417 · 2020
TacoxDNA: a user‐friendly web server for simulations of complex DNA structures, from single strands to origami
10.1002/jcc.26029 · 2019
PyMOL: an open-source molecular graphics tool. CCP4 newsletter on protein crystallography
2002
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
10.1186/1758-2946-4-17 · 2012
Optimization and computational studies evaluating molecular dynamics of EDA cored polymeric dendrimer
10.1038/s41598-020-77540-x · 2020
In silico identification of Tretinoin as a SARS-CoV-2 envelope (E) protein ion channel inhibitor
10.1016/j.compbiomed.2020.104063 · 2020
N.M.R. AND MOLECULAR-MODELLING STUDIES OF THE SOLUTION CONFORMATION OF HEPARIN
10.2210/pdb1hpn/pdb · 1995
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2
10.2210/pdb6m0j/pdb · 2020
ZDOCK server: interactive docking prediction of protein–protein complexes and symmetric multimers
10.1093/bioinformatics/btu097 · 2014
CHARMM general force field: a force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields
10.1002/jcc.21367 · 2009
HawkDock: a web server to predict and analyze the protein–protein complex based on computational docking and MM/GBSA
10.1093/nar/gkz397 · 2019
New biothreat of JN.1 variant SARS CoV-2: viral genome, mutations and comparison with Delta and Omicron variants—a brief commentary
10.32113/idtm_20243_1374 · doi-reference
A logic-gated nanorobot for targeted transport of molecular payloads
10.1126/science.1214081 · doi-reference
Modeling and investigating the behavior of triangular origami DNA under the influence of laboratory temperature
10.22034/stme.2022.162701 · doi-reference
Nanotechnology-based strategies against SARS-CoV-2 variants
10.1038/s41565-022-01174-5 · doi-reference
Heparin dosing regimen optimization in veno-arterial extracorporeal membrane oxygenation: a pharmacokinetic analysis
10.3390/pharmaceutics16060770 · doi-reference
Using heparin molecules to manage COVID‐2019
10.1002/rth2.12353 · doi-reference
Toward optimal heparin dosing by comparing multiple machine learning methods: retrospective study
10.2196/17648 · doi-reference
Conformational flexibility of spermidine3+ interacting with DNA double helix
10.1016/j.molliq.2023.122828 · doi-reference
Spermine and spermidine SI-PPCs: molecular dynamics reveals enhanced biomolecular interactions
10.1016/j.ijbiomac.2024.134654 · doi-reference
Doxorubicin-loaded DNA origami nanostructures: stability in vitreous and their uptake and toxicity in ocular cells
10.1039/d4nr01995d · doi-reference
Designing DNA nanodevices for compatibility with the immune system of higher organisms
10.1038/nnano.2015.180 · doi-reference
Nanomechanical response of peptide-bound DNA as a model molecular bio-nanocomposite: a steered molecular dynamics study
10.1007/s00894-026-06875-5 · doi-reference
Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
10.1126/sciadv.abm0220 · doi-reference
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
10.1038/s41467-020-18174-5 · doi-reference
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
10.1038/s41594-020-0469-6 · doi-reference
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
10.3389/fmolb.2022.912887 · doi-reference
Broad-spectrum small-molecule inhibitors of the SARS-CoV-2 Spike—ACE2 protein–protein interaction from a chemical space of privileged protein binders
10.3390/ph15091084 · doi-reference
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
10.1021/acsinfecdis.1c00070 · doi-reference
Small molecule therapeutics to destabilize the ACE2-RBD complex: a molecular dynamics study
10.1016/j.bpj.2021.06.016 · doi-reference
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
10.7150/thno.65563 · doi-reference
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
10.1038/s41598-021-90348-7 · doi-reference
Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes
10.1186/s12985-024-02304-2 · doi-reference
The study of the binding ability of antimicrobial peptides to spike protein of the coronavirus by docking and molecular dynamics simulation
10.34172/jhbmi.2024.07 · doi-reference
Heparin-assisted amyloidogenesis uncovered through molecular dynamics simulations
10.1021/acsomega.2c01034 · doi-reference
Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein
10.1016/j.csbj.2023.03.029 · doi-reference
g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations
10.1021/ci500020m · doi-reference
RBD double mutations of SARS-CoV-2 strains increase transmissibility through enhanced interaction between RBD and ACE2 Receptor
10.3390/v14010001 · doi-reference
The Omicron variant BA.2.86.1 of SARS- CoV-2 demonstrates an altered interaction network and dynamic features to enhance the interaction with the hACE2
10.1038/s41598-025-89548-2 · doi-reference
Mutations of SARS-CoV-2 RBD may alter its molecular structure to improve its infection efficiency
10.3390/biom11091273 · doi-reference
Counterion-dependent mechanisms of DNA origami nanostructure stabilization revealed by atomistic molecular simulation
10.1021/acsnano.9b05650 · doi-reference
Design and simulation of polycationic nano-linkers for connecting polyanions together
10.22034/stme.2025.507293.1107 · doi-reference